{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:59:12Z","timestamp":1781913552509,"version":"3.54.5"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009675","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000}}],"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"crossref","award":["EP\/L016044\/1"],"award-info":[{"award-number":["EP\/L016044\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AstraZeneca"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline plc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011111","name":"UCB UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Identifying the epitope of an antibody is a key step in understanding its function and its potential as a therapeutic. Sequence-based clonal clustering can identify antibodies with similar epitope complementarity, however, antibodies from markedly different lineages but with similar structures can engage the same epitope. We describe a novel computational method for epitope profiling based on structural modelling and clustering. Using the method, we demonstrate that sequence dissimilar but functionally similar antibodies can be found across the Coronavirus Antibody Database, with high accuracy (92% of antibodies in multiple-occupancy structural clusters bind to consistent domains). Our approach functionally links antibodies with distinct genetic lineages, species origins, and coronavirus specificities. This indicates greater convergence exists in the immune responses to coronaviruses than is suggested by sequence-based approaches. Our results show that applying structural analytics to large class-specific antibody databases will enable high confidence structure-function relationships to be drawn, yielding new opportunities to identify functional convergence hitherto missed by sequence-only analysis.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009675","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T13:31:32Z","timestamp":1639402292000},"page":"e1009675","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodies"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-0173","authenticated-orcid":true,"given":"Sarah A.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-5297","authenticated-orcid":true,"given":"Matthew I. J.","family":"Raybould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2579-0307","authenticated-orcid":true,"given":"Constantin","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4029-6902","authenticated-orcid":true,"given":"Wing Ki","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5931-2437","authenticated-orcid":true,"given":"Claire","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Deane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"issue":"5","key":"pcbi.1009675.ref001","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bioinformatics\/btaa739","article-title":"CoV-AbDab: the coronavirus antibody database","volume":"37","author":"MI Raybould","year":"2021","journal-title":"Bioinformatics"},{"issue":"6485","key":"pcbi.1009675.ref002","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"R Yan","year":"2020","journal-title":"Science"},{"issue":"1","key":"pcbi.1009675.ref003","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1038\/s41467-020-18319-6","article-title":"Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor","volume":"11","author":"J Yang","year":"2020","journal-title":"Nature Communications"},{"key":"pcbi.1009675.ref004","doi-asserted-by":"crossref","first-page":"605170","DOI":"10.3389\/fimmu.2020.605170","article-title":"Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures","volume":"11","author":"JD Galson","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"pcbi.1009675.ref005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-020-20095-2","article-title":"Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray","volume":"12","author":"RR de Assis","year":"2021","journal-title":"Nature Communications"},{"issue":"1","key":"pcbi.1009675.ref006","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2004.10.016","article-title":"Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine","volume":"331","author":"P Zhao","year":"2005","journal-title":"Virology"},{"key":"pcbi.1009675.ref007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00899","article-title":"The Pipeline Repertoire for Ig-Seq Analysis","volume":"10","author":"L L\u00f3pez-Santib\u00e1\u00f1ez-J\u00e1come","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"pcbi.1009675.ref008","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3389\/fimmu.2017.01753","article-title":"How B-Cell Receptor Repertoire Sequencing Can Be Enriched with Structural Antibody Data","volume":"8","author":"A Kovaltsuk","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"pcbi.1009675.ref009","doi-asserted-by":"crossref","first-page":"1869406","DOI":"10.1080\/19420862.2020.1869406","article-title":"A computational method for immune repertoire mining that identifies novel binders from different clonotypes, demonstrated by identifying anti-pertussis toxoid antibodies","volume":"13","author":"E Richardson","year":"2021","journal-title":"mAbs"},{"issue":"1","key":"pcbi.1009675.ref010","doi-asserted-by":"crossref","first-page":"1873478","DOI":"10.1080\/19420862.2021.1873478","article-title":"Ab-Ligity: Identifying sequence-dissimilar antibodies that bind to the same epitope","volume":"13","author":"WK Wong","year":"2021","journal-title":"mAbs"},{"issue":"7744","key":"pcbi.1009675.ref011","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-019-0934-8","article-title":"High frequency of shared clonotypes in human B cell receptor repertoires","volume":"566","author":"C Soto","year":"2019","journal-title":"Nature"},{"issue":"7821","key":"pcbi.1009675.ref012","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"DF Robbiani","year":"2020","journal-title":"Nature"},{"issue":"1","key":"pcbi.1009675.ref013","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-020-00263-y","article-title":"Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals","volume":"5","author":"F Zhang","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"4","key":"pcbi.1009675.ref014","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","article-title":"A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model","volume":"183","author":"J Kreye","year":"2020","journal-title":"Cell"},{"key":"pcbi.1009675.ref015","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3389\/fimmu.2021.678570","article-title":"Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses","volume":"12","author":"G Bullen","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"pcbi.1009675.ref016","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","article-title":"Maturation and persistence of the anti-SARS-CoV-2 memory B cell response","volume":"184","author":"A Sokal","year":"2021","journal-title":"Cell"},{"issue":"2","key":"pcbi.1009675.ref017","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.immuni.2020.06.024","article-title":"Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease","volume":"53","author":"C Schulthei\u00df","year":"2020","journal-title":"Immunity"},{"issue":"8","key":"pcbi.1009675.ref018","doi-asserted-by":"crossref","first-page":"109173","DOI":"10.1016\/j.celrep.2021.109173","article-title":"Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19","volume":"35","author":"Z Montague","year":"2021","journal-title":"Cell Reports"},{"issue":"4","key":"pcbi.1009675.ref019","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.chom.2020.09.002","article-title":"Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2","volume":"28","author":"SCA Nielsen","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"7819","key":"pcbi.1009675.ref020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"B Ju","year":"2020","journal-title":"Nature"},{"issue":"6507","key":"pcbi.1009675.ref021","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.abd2321","article-title":"Structural basis of a shared antibody response to SARS-CoV-2","volume":"369","author":"M Yuan","year":"2020","journal-title":"Science"},{"key":"pcbi.1009675.ref022","article-title":"Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients","author":"H Xiang","year":"2021","journal-title":"Human Immunology"},{"issue":"2","key":"pcbi.1009675.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1007636","article-title":"Structural diversity of B-cell receptor repertoires along the B-cell differentiation axis in humans and mice","volume":"16","author":"A Kovaltsuk","year":"2020","journal-title":"PLOS Computational Biology"},{"issue":"3","key":"pcbi.1009675.ref024","article-title":"Public Baseline and Shared Response Structures Support the Theory of Antibody Repertoire Functional Commonality","volume":"17","author":"MIJ Raybould","year":"2021","journal-title":"PLoS Computational Biology"},{"issue":"1","key":"pcbi.1009675.ref025","doi-asserted-by":"crossref","first-page":"1729683","DOI":"10.1080\/19420862.2020.1729683","article-title":"Understanding the human antibody repertoire","volume":"12","author":"AR Rees","year":"2020","journal-title":"MAbs"},{"issue":"7744","key":"pcbi.1009675.ref026","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-019-0879-y","article-title":"Commonality despite exceptional diversity in the baseline human antibody repertoire","volume":"566","author":"B Briney","year":"2019","journal-title":"Nature"},{"key":"pcbi.1009675.ref027","article-title":"Private Antibody Repertoires Are Public","author":"R Arora","year":"2020","journal-title":"bioRxiv"},{"issue":"8","key":"pcbi.1009675.ref028","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","article-title":"The antigenic anatomy of SARS-CoV-2 receptor binding domain","volume":"184","author":"W Dejnirattisai","year":"2021","journal-title":"Cell"},{"issue":"9","key":"pcbi.1009675.ref029","doi-asserted-by":"crossref","first-page":"e1009380","DOI":"10.1371\/journal.pcbi.1009380","article-title":"Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants","volume":"17","author":"R Yin","year":"2021","journal-title":"PLoS Computational Biology"},{"issue":"6","key":"pcbi.1009675.ref030","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/prot.22658","article-title":"FREAD revisited: Accurate loop structure prediction using a database search algorithm","volume":"78","author":"Y Choi","year":"2010","journal-title":"Proteins"},{"issue":"7","key":"pcbi.1009675.ref031","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1039\/c1mb05223c","article-title":"Predicting antibody complementarity determining region structures without classification","volume":"12","author":"Y Choi","year":"2011","journal-title":"Molecular BioSystems"},{"issue":"D1","key":"pcbi.1009675.ref032","doi-asserted-by":"crossref","first-page":"D1140","DOI":"10.1093\/nar\/gkt1043","article-title":"SAbDab: the structural antibody database","volume":"42","author":"J Dunbar","year":"2013","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"pcbi.1009675.ref033","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0145-305X(02)00039-3","article-title":"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains","volume":"27","author":"MP Lefranc","year":"2003","journal-title":"Developmental & Comparative Immunology"},{"issue":"7","key":"pcbi.1009675.ref034","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/19420862.2016.1205773","article-title":"ABodyBuilder: Automated antibody structure prediction with data\u2013driven accuracy estimation","volume":"8","author":"J Leem","year":"2016","journal-title":"mAbs"},{"issue":"7839","key":"pcbi.1009675.ref035","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"CO Barnes","year":"2020","journal-title":"Nature"},{"issue":"6496","key":"pcbi.1009675.ref036","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Y Wu","year":"2020","journal-title":"Science"},{"issue":"593","key":"pcbi.1009675.ref037","doi-asserted-by":"crossref","first-page":"eabf1906","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates","volume":"13","author":"BE Jones","year":"2021","journal-title":"Science Translational Medicine"},{"issue":"4","key":"pcbi.1009675.ref038","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2020.09.035","article-title":"Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy","volume":"183","author":"S Du","year":"2020","journal-title":"Cell"},{"issue":"10","key":"pcbi.1009675.ref039","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.cell.2021.03.027","article-title":"SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms","volume":"184","author":"SA Clark","year":"2021","journal-title":"Cell"},{"issue":"7819","key":"pcbi.1009675.ref040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"R Shi","year":"2020","journal-title":"Nature"},{"issue":"6506","key":"pcbi.1009675.ref041","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"TF Rogers","year":"2020","journal-title":"Science"},{"issue":"6","key":"pcbi.1009675.ref042","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.immuni.2020.10.023","article-title":"Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity","volume":"53","author":"H Liu","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"pcbi.1009675.ref043","doi-asserted-by":"crossref","first-page":"108274","DOI":"10.1016\/j.celrep.2020.108274","article-title":"An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain","volume":"33","author":"NC Wu","year":"2020","journal-title":"Cell Reports"},{"issue":"12","key":"pcbi.1009675.ref044","first-page":"1","article-title":"A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody","volume":"16","author":"NC Wu","year":"2020","journal-title":"PLOS Pathogens"},{"issue":"1","key":"pcbi.1009675.ref045","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1038\/s41467-020-19231-9","article-title":"Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation","volume":"11","author":"NK Hurlburt","year":"2020","journal-title":"Nature Communications"},{"issue":"10","key":"pcbi.1009675.ref046","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41594-020-0480-y","article-title":"Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient","volume":"27","author":"D Zhou","year":"2020","journal-title":"Nature Structural & Molecular Biology"},{"issue":"1","key":"pcbi.1009675.ref047","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1038\/s41467-021-23825-2","article-title":"Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers","volume":"12","author":"E Rujas","year":"2021","journal-title":"Nature Communications"},{"issue":"1","key":"pcbi.1009675.ref048","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/s41467-021-22926-2","article-title":"A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes","volume":"12","author":"Y Guo","year":"2021","journal-title":"Nature Communications"},{"issue":"1","key":"pcbi.1009675.ref049","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41467-020-20602-5","article-title":"A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein","volume":"12","author":"C Kim","year":"2021","journal-title":"Nature Communications"},{"issue":"4","key":"pcbi.1009675.ref050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology","volume":"183","author":"L Piccoli","year":"2020","journal-title":"Cell"},{"issue":"4","key":"pcbi.1009675.ref051","doi-asserted-by":"crossref","first-page":"109433","DOI":"10.1016\/j.celrep.2021.109433","article-title":"A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations","volume":"36","author":"F Bertoglio","year":"2021","journal-title":"Cell Reports"},{"issue":"9","key":"pcbi.1009675.ref052","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41594-020-0469-6","article-title":"Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2","volume":"27","author":"J Huo","year":"2020","journal-title":"Nature Structural & Molecular Biology"},{"issue":"3","key":"pcbi.1009675.ref053","first-page":"1","article-title":"A high-affinity RBD-targeting nanobody improves fusion partner\u2019s potency against SARS-CoV-2","volume":"17","author":"H Yao","year":"2021","journal-title":"PLOS Pathogens"},{"issue":"6523","key":"pcbi.1009675.ref054","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.abe4747","article-title":"Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2","volume":"370","author":"Y Xiang","year":"2020","journal-title":"Science"},{"issue":"5","key":"pcbi.1009675.ref055","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","article-title":"Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies","volume":"181","author":"D Wrapp","year":"2020","journal-title":"Cell"},{"issue":"6530","key":"pcbi.1009675.ref056","doi-asserted-by":"crossref","first-page":"eabe6230","DOI":"10.1126\/science.abe6230","article-title":"Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape","volume":"371","author":"PA Koenig","year":"2021","journal-title":"Science"},{"issue":"1","key":"pcbi.1009675.ref057","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1038\/s41467-021-24905-z","article-title":"A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection","volume":"12","author":"T Li","year":"2021","journal-title":"Nature Communications"},{"issue":"1","key":"pcbi.1009675.ref058","doi-asserted-by":"crossref","first-page":"108950","DOI":"10.1016\/j.celrep.2021.108950","article-title":"Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class","volume":"35","author":"M Rapp","year":"2021","journal-title":"Cell Reports"},{"issue":"5","key":"pcbi.1009675.ref059","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","article-title":"Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity","volume":"184","author":"EC Thomson","year":"2021","journal-title":"Cell"},{"key":"pcbi.1009675.ref060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109771","article-title":"Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses","volume":"37","author":"BB Banach","year":"2021","journal-title":"Cell Reports"},{"issue":"7","key":"pcbi.1009675.ref061","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/bioinformatics\/btz921","article-title":"Logomaker: beautiful sequence logos in Python","volume":"36","author":"A Tareen","year":"2020","journal-title":"Bioinformatics"},{"issue":"3","key":"pcbi.1009675.ref062","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jmb.2016.12.004","article-title":"Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures","volume":"429","author":"HC Jubb","year":"2017","journal-title":"Journal of Molecular Biology"},{"issue":"9","key":"pcbi.1009675.ref063","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein","volume":"26","author":"SJ Zost","year":"2020","journal-title":"Nature Medicine"},{"issue":"16","key":"pcbi.1009675.ref064","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.cell.2021.06.021","article-title":"In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies","volume":"184","author":"D Li","year":"2021","journal-title":"Cell"},{"issue":"6504","key":"pcbi.1009675.ref065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"PJM Brouwer","year":"2020","journal-title":"Science"},{"issue":"7815","key":"pcbi.1009675.ref066","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"D Pinto","year":"2020","journal-title":"Nature"},{"issue":"7491","key":"pcbi.1009675.ref067","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"BE Correia","year":"2014","journal-title":"Nature"},{"key":"pcbi.1009675.ref068","first-page":"837","article-title":"A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2","volume":"12","author":"X Han","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"pcbi.1009675.ref069","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molimm.2004.06.032","article-title":"Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus","volume":"42","author":"MJ Gubbins","year":"2005","journal-title":"Molecular Immunology"},{"issue":"6","key":"pcbi.1009675.ref070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.chom.2018.05.001","article-title":"Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection","volume":"23","author":"I Setliff","year":"2018","journal-title":"Cell host & microbe"},{"issue":"2","key":"pcbi.1009675.ref071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0247253","article-title":"Convergent antibody evolution and clonotype expansion following influenza virus vaccination","volume":"16","author":"D Forgacs","year":"2021","journal-title":"PLOS One"},{"issue":"25","key":"pcbi.1009675.ref072","first-page":"9823","article-title":"How antibody repertoire data are changing antibody science","volume":"295","author":"C Marks","year":"2021","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"pcbi.1009675.ref073","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.immuni.2021.08.013","article-title":"A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants","volume":"54","author":"AJ Schmitz","year":"2021","journal-title":"Immunity"},{"issue":"6519","key":"pcbi.1009675.ref074","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.abe3354","article-title":"Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms","volume":"370","author":"MA Tortorici","year":"2020","journal-title":"Science"},{"issue":"7873","key":"pcbi.1009675.ref075","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"J Jumper","year":"2021","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009675","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T13:57:41Z","timestamp":1640267861000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009675"}},"subtitle":[],"editor":[{"given":"Franca","family":"Fraternali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":75,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009675","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.12.439478","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,13]]}}}